Steve Cohen: portfolio of Point72 Asset Management
Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 14, 2025. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q4 2024. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 35.7B USD
- Positions
- 1,190
- Share of the ten largest
- 13.3%
The ten largest positions Q4 2024
- Amazon 2.6%new
- Microsoft 2.0%▲ +356.9%
- Nvidia 1.6%▲ +13.5%
- Taiwan Semiconductor Manufacturing (ADR) 1.4%▲ +106.7%
- Coca-Cola Company (The) 1.0%▲ +450.3%
- AT&T 1.0%new
- Intuit 1.0%▲ +2,450.4%
- Walt Disney Company (The) 1.0%new
- Arista Networks 0.9%▼ −14.0%
- Adobe Inc. 0.9%▲ +180.7%
Show all positions of this quarter
Choose a quarter (50 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
All positions Q4 2024
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| CME CME Group | < 0.1% | 15,000 | 3.5M USD | −84.7% reduced | Q2 2014 or earlier 43 quarters |
| DD DuPont | < 0.1% | 136,605 | 10.4M USD | −52.0% reduced | Q2 2019 23 quarters |
| Alphatec HLDGS Inc | < 0.1% | 598,003 | 5.5M USD | −30.5% reduced | Q4 2020 17 quarters |
| ANET Arista Networks | 0.9% | 3,021,154 | 333.9M USD | −14.0% reducedafter 4:1 stock split | Q1 2021 16 quarters |
| VMC Vulcan Materials Company | < 0.1% | 55,989 | 14.4M USD | −47.1% reduced | Q1 2021 16 quarters |
| Olin Corp | < 0.1% | 29,444 | 995.2K USD | −92.3% reduced | Q1 2021 16 quarters |
| Triumph Group Inc New | < 0.1% | 866,936 | 16.2M USD | −22.0% reduced | Q2 2021 15 quarters |
| BSX Boston Scientific | 0.6% | 2,245,799 | 200.6M USD | −33.6% reduced | Q3 2021 14 quarters |
| Bath & Body Works Inc | 0.4% | 3,873,396 | 150.2M USD | −22.8% reduced | Q3 2021 14 quarters |
| Ambarella Inc | 0.2% | 802,280 | 58.4M USD | −6.9% reduced | Q3 2021 14 quarters |
| CRDO Credo Technology Group | 0.6% | 3,084,621 | 207.3M USD | −21.2% reduced | Q1 2022 12 quarters |
| Bellring Brands Inc | 0.3% | 1,537,883 | 115.9M USD | −40.6% reduced | Q1 2022 12 quarters |
| Webster Finl Corp | 0.2% | 1,222,758 | 67.5M USD | −11.8% reduced | Q1 2022 12 quarters |
| COO Cooper Companies (The) | < 0.1% | 179,139 | 16.5M USD | −5.0% reduced | Q1 2022 12 quarters |
| Health Catalyst Inc | < 0.1% | 215,160 | 1.5M USD | −58.4% reduced | Q1 2022 12 quarters |
| Axsome Therapeutics Inc | < 0.1% | 185,138 | 15.7M USD | −65.9% reduced | Q2 2022 11 quarters |
| Joyy Inc | < 0.1% | 312,927 | 13.1M USD | −12.6% reduced | Q2 2022 11 quarters |
| Mastec Inc | 0.3% | 734,211 | 100.0M USD | −3.9% reduced | Q3 2022 10 quarters |
| UAL United Airlines Holdings | 0.1% | 551,933 | 53.6M USD | −64.9% reduced | Q3 2022 10 quarters |
| Biohaven Ltd | < 0.1% | 922,965 | 34.5M USD | −38.5% reduced | Q3 2022 10 quarters |
| Rogers Communications Inc | < 0.1% | 937,328 | 28.8M USD | −72.5% reduced | Q3 2022 10 quarters |
| Discover Finl Svcs | < 0.1% | 155,132 | 26.9M USD | −48.3% reduced | Q3 2022 10 quarters |
| Rxsight Inc | < 0.1% | 391,732 | 13.5M USD | −12.4% reduced | Q3 2022 10 quarters |
| Gibraltar Inds Inc | < 0.1% | 190,588 | 11.2M USD | −9.3% reduced | Q3 2022 10 quarters |
| Sterling Infrastructure Inc | < 0.1% | 29,695 | 5.0M USD | −76.2% reduced | Q3 2022 10 quarters |
| Helix Energy Solutions Grp I | < 0.1% | 277,835 | 2.6M USD | −82.1% reduced | Q3 2022 10 quarters |
| Wayfair Inc | < 0.1% | 13,200 | 585.0K USD | −83.4% reduced | Q3 2022 10 quarters |
| Keros Therapeutics Inc | < 0.1% | 1,592 | 25.2K USD | −99.8% reduced | Q3 2022 10 quarters |
| ISRG Intuitive Surgical | 0.5% | 338,696 | 176.8M USD | −22.6% reduced | Q4 2022 9 quarters |
| Qorvo Inc | 0.2% | 865,162 | 60.5M USD | −9.5% reduced | Q4 2022 9 quarters |
| Syndax Pharmaceuticals Inc | < 0.1% | 1,915,736 | 25.3M USD | −31.0% reduced | Q4 2022 9 quarters |
| Crown HLDGS Inc | < 0.1% | 182,822 | 15.1M USD | −51.5% reduced | Q4 2022 9 quarters |
| HAS Hasbro | < 0.1% | 193,171 | 10.8M USD | −75.1% reduced | Q4 2022 9 quarters |
| Liberty Broadband Corp | < 0.1% | 58,020 | 4.3M USD | −80.3% reduced | Q4 2022 9 quarters |
| Caribou Biosciences Inc | < 0.1% | 1,024,989 | 1.6M USD | −51.9% reduced | Q4 2022 9 quarters |
| Nlight Inc | < 0.1% | 24,400 | 256.0K USD | −57.8% reduced | Q4 2022 9 quarters |
| COF Capital One | 0.2% | 381,730 | 68.1M USD | −37.6% reduced | Q1 2023 8 quarters |
| Skechers U S A Inc | 0.2% | 975,797 | 65.6M USD | −58.6% reduced | Q1 2023 8 quarters |
| RAPID7 Inc | 0.2% | 1,485,477 | 59.8M USD | −54.2% reduced | Q1 2023 8 quarters |
| Livanova PLC | 0.1% | 1,036,248 | 48.0M USD | −50.5% reduced | Q1 2023 8 quarters |
| Cogent Biosciences Inc | 0.1% | 5,347,302 | 41.7M USD | −48.9% reduced | Q1 2023 8 quarters |
| JCI Johnson Controls | 0.1% | 513,449 | 40.5M USD | −58.6% reduced | Q1 2023 8 quarters |
| Reinsurance Grp Of America I | < 0.1% | 125,812 | 26.9M USD | −32.8% reduced | Q1 2023 8 quarters |
| WAB Wabtec | < 0.1% | 131,700 | 25.0M USD | −24.3% reduced | Q1 2023 8 quarters |
| Griffon Corp | < 0.1% | 272,065 | 19.4M USD | −42.5% reduced | Q1 2023 8 quarters |
| Patterson-Uti Energy Inc | < 0.1% | 1,844,659 | 15.2M USD | −45.9% reduced | Q1 2023 8 quarters |
| Topbuild Corp | < 0.1% | 41,546 | 12.9M USD | −54.4% reduced | Q1 2023 8 quarters |
| Heico Corp New | < 0.1% | 69,203 | 12.9M USD | −3.8% reduced | Q1 2023 8 quarters |
| Gds HLDGS Ltd | < 0.1% | 100,554 | 2.4M USD | −34.3% reduced | Q1 2023 8 quarters |
| Stride Inc | < 0.1% | 9,251 | 961.4K USD | −95.6% reduced | Q1 2023 8 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 longest-held of 314 positions.
Plus 804 option positions, value of the underlying shares as reported 8.9B USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- SPDR S&P 500 ETF TR Call 1.7B USD
- SPDR S&P 500 ETF TR Put 1.7B USD
- Ishares TR Put 239.7M USD
- Invesco QQQ TR Put 162.3M USD
- Apple Inc. Call 118.6M USD
- Hershey Company (The) Call 70.8M USD
- Novo Nordisk (ADR) Put 68.8M USD
- Select Sector SPDR TR Put 65.7M USD
- Ishares TR Call 61.9M USD
- Apple Inc. Put 54.9M USD
Plus 44 positions in convertible bonds and bonds worth 765.0M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Axon Enterprise Inc principal 20.0M USD 52.2M USD
- Microstrategy Inc principal 23.0M USD 47.7M USD
- Bridgebio Pharma Inc principal 37.5M USD 39.3M USD
- Lumentum HLDGS Inc principal 33.5M USD 37.0M USD
- Cytokinetics Inc principal 29.7M USD 35.5M USD
- Ascendis Pharma A/S principal 31.5M USD 34.7M USD
- Ncl Corp Ltd principal 32.6M USD 34.2M USD
- Mirum Pharmaceuticals Inc principal 18.9M USD 28.8M USD
- Ncl Corp Ltd principal 20.0M USD 28.7M USD
- Insulet Corp principal 22.5M USD 28.5M USD
Breakdown by sector
- Technology 18.7%
- Consumer Discretionary 6.4%
- Health Care 6.0%
- Industrials 5.4%
- Financials 4.1%
- Utilities 3.5%
- Communication Services 3.5%
- Consumer Staples 3.5%
- Energy 2.6%
- Materials 1.8%
- Real Estate 1.2%
- not in our coverage 43.1%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors